Try GOLD - Free
INDIA'S COUGH SYRUP CONTROVERSY: COLLAPSE OF REGULATION AND CRIMINAL LIABILITY
The Business Guardian
|October 22, 2025
Cough syrups are a common remedy for relieving symptoms like colds, allergies, and respiratory infections.
Among them, Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup have been widely used in different regions. These medications are designed to ease cough, congestion, and other discomforts in both children and adults. However, concerns have recently emerged regarding their safety and quality.
The recent deaths of children due to consumption of cough syrup have exposed gaps in pharmaceutical safety oversight. At least 16 children, mostly under five years of age, died after consuming contaminated Coldrif cough syrup manufactured by Sresan Pharmaceuticals in Tamil Nadu. Cough syrup crisis was a public health tragedy involving the deaths of several children in Madhya Pradesh and Rajasthan after consuming contaminated cough syrups.In Chhindwara district of Madhya Pradesh, at least 24 children died after taking Coldrif syrup manufactured by Sresan Pharma, which was later found to contain diethylene glycol (DEG), a toxic chemical used in industrial solvents. Around the same period, three children in Rajasthan died after consuming Kufdil and other dextromethorphan-based syrups distributed under the state's free medicine scheme.
The incident led to widespread criticism of India's drug regulatory system and renewed concerns over pharmaceutical quality control. It also drew international attention, as it followed earlier cases of diethylene glycol poisoning linked to Indian-made syrups in Gambia and Uzbekistan.
INDIA'S HISTORY WITH TOXIC SYRUPS The Coldrif tragedy is not an isolated incident. India has witnessed several cough syrup deaths over the past three decades: • In 1998, 33 children died in Gurugram after consuming syrup containing DEG, with 150 children hospitalized with acute kidney failure in Delhi.
• In 2020, 17 children died in Jammu and Kashmir's Ramnagar after taking contaminated cough syrup with DEG.
This story is from the October 22, 2025 edition of The Business Guardian.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM The Business Guardian
The Business Guardian
ELIMINATING DUST IN CAPITAL IS OUR GOVT'S PRIORITY: CM GUPTA
Delhi Chief Minister Rekha Gupta said on Friday that her government is working on multiple fronts to effectively and sustainably control pollution in the capital.
2 mins
December 13, 2025
The Business Guardian
FED RATE CUT EASES PRESSURE ON RUPEE; INDIA SEEN STABLE ON FX, BONDS: REPORT
The report notes that the Fed’s December policy vote was deeply divided
2 mins
December 13, 2025
The Business Guardian
Shilpkari of Rajasthan: The Art of Traditional Craftsmanship
Shilpkari, or traditional Rajasthani craftsmanship, is a significant part of Rajasthan's rich cultural heritage.
1 mins
December 13, 2025
The Business Guardian
Lok Adalat Awards: Final Means Final, SC Holds
Final, SC Holds
2 mins
December 13, 2025
The Business Guardian
LG Saxena gives nod for one-rank-higher honorary titles for retiring Delhi Police personnel
Delhi Lieutenant Governor VK Saxena on Friday approved the grant of Honorary Ranks, one level above their existing posts, to Delhi Police personnel from Constable to Sub-Inspector ranks on the day of their superannuation.
1 min
December 13, 2025
The Business Guardian
GEMS OF RAJASTHAN: CRAFTING LEGACY AND LUXURY
Rajasthan is famous for its beautiful gemstones, known for their high quality, vibrant colors, and unique beauty.
2 mins
December 13, 2025
The Business Guardian
HC directs intermediaries to act on Gavaskar's complaint
The Delhi High Court on Friday issued directions to intermediaries to treat Sunil Gavaskar’s lawsuit as a formal complaint and begin the take-down process for allegedly infringing content.
1 min
December 13, 2025
The Business Guardian
South Korean Intellectual Property Office upgraded to Ministry
Do India need to closely monitor this strategic reorganization move by the government!
3 mins
December 13, 2025
The Business Guardian
India bets on generative AI to reshape drug discovery, says Union Minister
India will rely on generative AI to accelerate drug discovery and bolster clinical research, Minister of State for Science and Technology Jitendra Singh said on Friday, adding that fears that the technology will replace scientists are unfounded and that AI will only enhance decision-making, not replace experts.
1 min
December 13, 2025
The Business Guardian
India Notifies DPDP Rules 2025
India’s data-protection framework took a major step in November when the Digital Personal Data Protection (DPDP) Rules, 2025 were notified.
1 mins
December 13, 2025
Listen
Translate
Change font size
